Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Urine Studies I: Urinalysis

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...

Urine Studies II: Urine Culture and Sensitivity Test

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...

Drug Elimination by Renal Route: Tubular Reabsorption

Drug Elimination by Renal Route: Tubular Reabsorption

During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. However, the majority of drugs are either weak acids or weak bases, and their ionization level is dependent on pH. By altering the pH of urine, the...

Drug Excretion: Miscellaneous Routes

Drug Excretion: Miscellaneous Routes

Drug excretion involves various organs, including the liver, intestines, skin, and eyes. In the case of drugs or toxins, they can be actively secreted into bile by transporters in the hepatocyte's canalicular membrane. These substances enter the GI tract during digestion and may be reabsorbed into the body from the intestine. This process, known as enterohepatic recycling, can significantly prolong the presence and effects of a substance in the body. To interrupt this cycle, specific substances...

Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa

The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a drug,...

Renal Drug Excretion: Tubular Reabsorption

Renal Drug Excretion: Tubular Reabsorption

Tubular reabsorption, a process occurring post-glomerular filtration of drugs in the renal tubule, is a critical determinant of drug half-life. During the process of renal excretion, as the glomerular filtrate progresses to the distal convoluted tubule (DCT), drugs that are highly permeable, lipophilic, and nonionized undergo passive reabsorption from the tubular fluid into the surrounding peritubular capillaries. This reabsorption process restricts their elimination through the kidneys. This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Use of gabapentin with or without a prescription in substance use treatment settings: A national analysis of urine drug testing data, 2016-2023.

Drug and alcohol dependence·2026

Same author

Association of Patients' Direct Addition of Buprenorphine to Urine Drug Test Specimens With Clinical Factors in Opioid Use Disorder.

JAMA psychiatry·2023

Same author

Preliminary validation of the Diversion Risk Scale (DRS): Using environmental and individual factors to predict opioid-related diversion events.

Journal of opioid management·2023

Same author

Definitive urine drug test findings in patients prescribed opioids for pain from a large national database.

Journal of opioid management·2022

Same author

Analysis of Urine Drug Test Results From Substance Use Disorder Treatment Practices and Overdose Mortality Rates, 2013-2020.

JAMA network open·2022

Same author

Concomitant use of benzodiazepines in chronic pain patients adherent to extended-release tapentadol or oxycodone treatment-A retrospective claims analysis.

Journal of opioid management·2021

Search research articles

Related Experiment Video

Updated: May 30, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Ethical considerations in urine drug testing.

Steven D Passik¹, Kenneth L Kirsh

¹Psychosomatic Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Journal of Pain & Palliative Care Pharmacotherapy

|August 4, 2011

Summary

Washington

Area of Science:

Medical Ethics
Public Health Law
Pain Management

Background:

A recent Washington House Bill mandates urine drug testing for pain patients.
This has raised concerns regarding patient rights under the Fourth and Fourteenth Amendments.
Issues of informed consent and warrantless searches are central to the debate.

Purpose of the Study:

To analyze the legal and ethical implications of mandatory urine drug testing for pain patients.
To contextualize these mandates within risk management and patient stratification strategies.
To explore the intersection of patient rights, social justice, and healthcare policy.

Main Methods:

Commentary and analysis of legal and ethical principles.
Discussion of risk management and stratification in pain patient care.

More Related Videos

Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing

Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing

Published on: May 8, 2021

Related Experiment Videos

Last Updated: May 30, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

Published on: April 23, 2019

Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing

Low-Cost, Volume-Controlled Dipstick Urinalysis for Home-Testing

Published on: May 8, 2021

Consideration of patient autonomy, beneficence, nonmaleficence, and social justice.

Main Results:

Mandatory drug testing may infringe upon Fourth and Fourteenth Amendment rights.
True patient consent and the potential for warrantless searches are significant concerns.
A tailored approach considering cost burden and social justice is necessary.

Conclusions:

Urine drug testing mandates for pain patients require careful consideration of constitutional rights.
Ethical principles including autonomy, beneficence, and nonmaleficence must be balanced.
Social justice implications and the financial burden of testing warrant attention in policy development.